|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Posatex
|
|
Active substances:
|
|
|
ATC code:
|
QS02CA93
|
|
Dosage form:
|
ear drops, suspension
|
|
Strength:
|
0,9mg+0,9mg+8,5mg 1ml
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Indication:
|
Treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with
bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular Malassezia
pachydermatis.
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
Intervet International B.V.
|
|
Marketing authorization number:
|
EU/2/08/081
|
|
Marketing authorization issued on:
|
June 25, 2008
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1361742
|
Posatex
|
ear drops, suspension
|
0,9mg +0,9mg +8,5mg 1ml 8.8ml 1TK
|
Prescription
|
|
|
06.09.2022
|
|
|
|
1361753
|
Posatex
|
ear drops, suspension
|
0,9mg +0,9mg +8,5mg 1ml 17.5ml 1TK
|
Prescription
|
|
|
|
|
|
|
1361764
|
Posatex
|
ear drops, suspension
|
0,9mg +0,9mg +8,5mg 1ml 35.1ml 1TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere